Overview
CNS Neuroscience & Therapeutics, published by Wiley (United Kingdom), published 2,119 papers in 2021–2025, and its papers received 29,455 citations in those years. Its h-index is 121 and its two-year mean citedness is 6.02. On the ITS Journal Score it ranks #1,212 of 62,158 ranked journals and #33 of 364 in Neuroscience.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 143 | 5,546 | 143 |
| 2021 | 203 | 5,068 | 203 |
| 2022 | 296 | 6,304 | 296 |
| 2023 | 503 | 9,033 | 503 |
| 2024 | 557 | 6,542 | 557 |
| 2025 | 560 | 2,508 | 560 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Journal of Neuroinflammation | Neuroscience | 89.1 | 1,615 | 100% |
| Molecular Neurobiology | Neuroscience | 85.0 | 3,381 | 40% |
| Glia | Neuroscience | 82.6 | 923 | 72% |
| Molecular Neurodegeneration | Medicine | 89.7 | 499 | 100% |
| Frontiers in Cellular Neuroscience | Neuroscience | 84.3 | 2,479 | 100% |
| Neurobiology of Disease | Medicine | 84.5 | 1,743 | 100% |
| Neurotoxicity Research | Neuroscience | 74.3 | 461 | 24% |
| NeuroMolecular Medicine | Neuroscience | 73.6 | 261 | 31% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 1755-5930
- Print ISSN: 1755-5930
- Electronic ISSN: 1755-5949
- Publisher: Wiley
- Listed in DOAJ: Yes (checked against DOAJ)
- Crossref: ISSN found in Crossref
- OpenAlex: S84392608
- Journal website: www.wiley.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of CNS Neuroscience & Therapeutics?
It is 83.2 out of 100, which places it #1,212 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of CNS Neuroscience & Therapeutics?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 6.02.
Is CNS Neuroscience & Therapeutics open access?
100% of its papers from 2021–2025 are recorded as open access, and it is listed in DOAJ.
Does CNS Neuroscience & Therapeutics charge a publication fee?
DOAJ records an article processing charge of US$4,550. Check the journal's website for the current fee and any waivers.